I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 18 studies | 40% ± 17% | |
| natural killer cell | 14 studies | 30% ± 16% | |
| CD16-negative, CD56-bright natural killer cell, human | 11 studies | 33% ± 14% | |
| innate lymphoid cell | 9 studies | 43% ± 20% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 22% ± 10% | |
| gamma-delta T cell | 6 studies | 34% ± 13% | |
| CD4-positive, alpha-beta T cell | 5 studies | 30% ± 5% | |
| CD8-positive, alpha-beta T cell | 5 studies | 26% ± 9% | |
| T cell | 4 studies | 22% ± 8% | |
| mast cell | 3 studies | 33% ± 13% | |
| T follicular helper cell | 3 studies | 30% ± 14% | |
| plasma cell | 3 studies | 27% ± 7% | |
| group 3 innate lymphoid cell | 3 studies | 43% ± 8% | |
| T-helper 17 cell | 3 studies | 29% ± 2% | |
| CD4-positive, alpha-beta cytotoxic T cell | 3 studies | 40% ± 13% | |
| mature NK T cell | 3 studies | 32% ± 11% |
